HomeDoravirine Lamivudine And Tenofovir Disoproxil FumarateDoravirine Lamivudine And Tenofovir Disoproxil Fumarate + Velpatasvir And Sofosbuvir

Does Doravirine Lamivudine And Tenofovir Disoproxil Fumarate Interact with Velpatasvir And Sofosbuvir?

Doravirine Lamivudine And Tenofovir Disoproxil Fumarate and Velpatasvir And Sofosbuvir have a moderate drug interaction according to U.S. FDA drug labeling data. Co-administration increases tenofovir plasma concentrations. Monitor for adverse reactions associated with tenofovir disoproxil fumarate. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Doravirine Lamivudine And Tenofovir Disoproxil Fumarate Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Velpatasvir And Sofosbuvir Class
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Doravirine Lamivudine And Tenofovir Disoproxil Fumarate and your doctor is considering prescribing Velpatasvir And Sofosbuvir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Doravirine Lamivudine And Tenofovir Disoproxil Fumarate(Delstrigo)+💊 Velpatasvir And Sofosbuvir(Sofosbuvir And Velpatasvir)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Drug B class
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Source
NLP:doravirine, lamivudine, and tenofovir disoproxil fumarate

What this means in plain English

Co-administration increases tenofovir plasma concentrations. Monitor for adverse reactions associated with tenofovir disoproxil fumarate.

About Doravirine Lamivudine And Tenofovir Disoproxil Fumarate and Velpatasvir And Sofosbuvir

Doravirine Lamivudine And Tenofovir Disoproxil Fumarate is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, while Velpatasvir And Sofosbuvir is a Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor. Doravirine Lamivudine And Tenofovir Disoproxil Fumarate is also sold under the brand name Delstrigo. Both medications are taken by mouth. Both Doravirine Lamivudine And Tenofovir Disoproxil Fumarate and Velpatasvir And Sofosbuvir carry an FDA boxed warning — the agency's most serious safety designation.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Doravirine Lamivudine And Tenofovir Disoproxil Fumarate and Velpatasvir And Sofosbuvir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.